Correlation Between Armata Pharmaceuticals and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armata Pharmaceuticals and Nuvectis Pharma, you can compare the effects of market volatilities on Armata Pharmaceuticals and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and Nuvectis Pharma.
Diversification Opportunities for Armata Pharmaceuticals and Nuvectis Pharma
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Armata and Nuvectis is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Armata Pharmaceuticals and Nuvectis Pharma
Given the investment horizon of 90 days Armata Pharmaceuticals is expected to generate 1.23 times more return on investment than Nuvectis Pharma. However, Armata Pharmaceuticals is 1.23 times more volatile than Nuvectis Pharma. It trades about 0.05 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about -0.02 per unit of risk. If you would invest 134.00 in Armata Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 101.00 from holding Armata Pharmaceuticals or generate 75.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Armata Pharmaceuticals vs. Nuvectis Pharma
Performance |
| Timeline |
| Armata Pharmaceuticals |
| Nuvectis Pharma |
Armata Pharmaceuticals and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Armata Pharmaceuticals and Nuvectis Pharma
The main advantage of trading using opposite Armata Pharmaceuticals and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.The idea behind Armata Pharmaceuticals and Nuvectis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |